The role of CD44 adhesion molecule in oral cavity cancer.

CD44 is an adhesion molecule, member of the transmembrane glucoprotein family, with large number of isoforms identified in many human tissues, with particularly high expression in proliferating cells and squamous cell epithelium. This review is focused on the role of CD44 in the carcinogenesis of the oral cavity with special emphasis on its potential use for diagnosis and prognosis of cancer of oral cavity.

[1]  A. Batistatou,et al.  The role of E-cadherin/catenin complex in laryngeal cancer. , 2005, Experimental oncology.

[2]  A. Batistatou,et al.  Integrins adhesion molecules and some of their ligands in laryngeal cancer. , 2005, Experimental oncology.

[3]  A. Batistatou,et al.  Integrin receptors and extracellular matrix components in parotid neoplasms. , 2005, Experimental oncology.

[4]  Y. Kudo,et al.  Upregulated CD44v9 Expression Inhibits the Invasion of Oral Squamous Cell Carcinoma Cells , 2004, Pathobiology.

[5]  F. Esteban,et al.  Adhesion molecule CD44 expression in non-tumour epithelium adjacent to tongue cancer. , 2004, Oral oncology.

[6]  I. Saloniemi,et al.  CD44v6 in developing, dysplastic and malignant oral epithelia. , 2003, Oral oncology.

[7]  S. Sato,et al.  Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells. , 2003, Oral oncology.

[8]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[9]  F. Pezzetti,et al.  CD44 as Prognostic Factor in Oral and Oropharyngeal Squamous Cell Carcinoma , 2002, The Journal of craniofacial surgery.

[10]  A. Franchi,et al.  Expression of CD44 standard and variant isoforms in parotid gland and parotid gland tumours. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  J. Sheehan,et al.  Hyaluronan: polysaccharide chaos to protein organisation. , 2001, Current opinion in structural biology.

[12]  J. Califano,et al.  Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  G. Snow,et al.  Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  G. Baretton,et al.  Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. , 1999, Oral oncology.

[15]  S. Goodison,et al.  CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.

[16]  J. Piffkó,et al.  Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity. , 1999, Cancer Detection and Prevention.

[17]  J. Regezi,et al.  Hyaluronan and CD44 expression in minor salivary gland tumors. , 2008, Oral diseases.

[18]  M. Sugiyama,et al.  Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[19]  M. Sherriff,et al.  Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  H. Degrendele,et al.  Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. , 1998, The Journal of clinical investigation.

[21]  D. Mangham,et al.  The normal structure and function of CD44 and its role in neoplasia. , 1998, Molecular pathology : MP.

[22]  S. Gansauge,et al.  Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma , 1997, Cancer.

[23]  M. Kunishi,et al.  Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. , 1997, International journal of oral and maxillofacial surgery.

[24]  E. Odell,et al.  Expression of CD44 variant exons by normal oral epithelia. , 1997, Oral oncology.

[25]  B. Toole,et al.  Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[26]  J. Piffkó,et al.  Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[27]  F. Watt,et al.  Altered expression of CD44 isoforms in squamous‐cell carcinomas and cell lines derived from them , 1996, International journal of cancer.

[28]  M. Zöller,et al.  EXPRESSION OF CD44 SPLICE VARIANTS IN SQUAMOUS EPITHELIA AND SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECK , 1996, The Journal of pathology.

[29]  S. Jalkanen,et al.  Does soluble CD44 reflect the clinical behavior of human cancer? , 1996, Current topics in microbiology and immunology.

[30]  J. Bell,et al.  CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. , 1994, International immunology.

[31]  J. Bos,et al.  A PCR-based method for the analysis of human CD44 splice products. , 1993, PCR methods and applications.

[32]  P. Herrlich,et al.  Splicing choice from ten variant exons establishes CD44 variability. , 1993, Nucleic acids research.

[33]  D. Tarin,et al.  Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.

[34]  C. Underhill,et al.  CD44: the hyaluronan receptor. , 1992, Journal of cell science.

[35]  C. Underhill,et al.  The hyaluronate receptor is preferentially expressed on proliferating epithelial cells , 1989, The Journal of cell biology.

[36]  S. Jalkanen,et al.  Human lymphocyte and lymphoma homing receptors. , 1987, Annual review of medicine.

[37]  C. Underhill,et al.  The role of hyaluronic acid in intercellular adhesion of cultured mouse cells. , 1978, Experimental cell research.